The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

Mexican drug cartels are turning thousands of Americans into fentanyl smugglers, sending an army of couriers who can easily ...

The U.S. FDA approved Bristol Myers Squibb's schizophrenia drug on Thursday, providing patients with a treatment option that ...

In 2024 alone, 37.7 million pills and more than 5,400 pounds of fentanyl powder have been seized – enough to produce 269 ...

Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.

The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...

US FDA Approves GE HealthCare's Diagnostic Drug for Heart Disease (Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

智通财经APP获悉，9月26日，美国FDA顾问小组将重点讨论施贵宝(BMY.US)的Opdivo (nivolumab)和默沙东(MRK.US)的Keytruda ...

Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh ...

智通财经APP获悉，美国食品和药物管理局(FDA)周四批准了由美国医药巨头百时美施贵宝公司(BMY.US)开发的Cobenfy(xanomeline以及trospium ...

2022年3月，诺华宣布FDA已经批准该公司的Pluvicto上市，用于治疗PSMA阳性转移性去势抵抗性前列腺癌 ...